Midgard Science

Labs / Assays & in vitro testing

FyoniBio

Berlin, Germany · fyonibio.com

ISO 9001 · GMP

FyoniBio develops biologics and provides bioanalytical support for clinical trials and biologic characterization. It works with biopharmaceutical programs from discovery and cell line development through process development, analytics, and clinical bioanalysis. The company is based in Berlin, Germany.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Cell Line Development

    Develops mammalian cell lines for biotherapeutics using CHO and human platforms, including tailored expression systems for complex molecules.

  • CHOFlow® Cell Line Development

    Provides a glycoengineered CHO platform for producing afucosylated monoclonal antibodies and other glycoproteins with enhanced ADCC.

  • CHOnamite® Cell Line Development

    Offers a CHO-based platform for high-yield production of biotherapeutics and classical mAb glycosylation.

  • GlycoExpress® Cell Line Development

    Provides a human expression platform for proteins that require authentic human post-translational modifications and complex glycosylation.

  • Process Development

    Supports upstream and downstream process development and optimization to prepare biologics for scalable manufacturing.

  • Analytical Services and Bioassays

    Performs biochemical analytics and bioassay development to characterize biologics across development stages.

  • Mass Spectrometry Analytics

    Uses mass spectrometry for characterization of critical quality attributes such as glycosylation, integrity, and PTMs.

  • Clinical Bioanalysis

    Develops and runs bioanalytical methods for PK, PD, and immunogenicity studies in clinical samples.

  • Functional and Potency Bioassays

    Develops and validates functional and potency assays for biologics.

  • Bioanalytical Support for Clinical Trials

    Provides GCLP-compliant bioanalysis of clinical samples for Phase I to IV studies.

  • Bioanalytical Characterization

    Characterizes biologics from feasibility through regulatory submission using analytical and functional methods.

What they work on

Modalities
Antibody, Bispecific, ADC, Oligonucleotide, Recombinant protein, Biosimilar
Species and models
CHO-K1, CHO-GS-KO, CHO-DG44, human cell lines, FcγRIIIa, NK cells
Assays and studies
PK assays, PD assays, immunogenicity assays, ADA assays, neutralizing antibody assays, biomarker analysis, SNP analysis, immune cell profiling, functional assays, ligand binding assays, cell-based assays, hybrid LC-MS/MS methods, and 3 more
Instruments and platforms
LC-MS, Octet BLI, DRX2, AlphaScreen, TÜV Rheinland
Scale and capacity
Analysis capacity of up to 10,000 samples per year, High yields > 12 g/L for some mAbs, High yields > 5 g/L in standard fed-batch processes, Stability over > 70 population doublings
Therapeutic areas
immuno-oncology
Turnaround
typically respond within 24 hours
What to send
blood-derived matrices like serum and plasma · tissue-based materials
Type
CRDMO
Sites
Berlin, Germany
Quality
ISO 9001:2015 (quality management systems) · GCLP-compliant (clinical bioanalysis) · ICH (bioanalytical and validation guidelines) · FDA (bioanalytical and validation guidelines) · EMA (bioanalytical and validation guidelines)
Serves
global
Founded
2022

Similar labs. Biofidus GmbH, Hope Medicine (HopeMed), Transcenta Holding, Aurigene Pharmaceutical Services

Found in a contract services directory. Listing built from fyonibio.com. Work here? Claim this listing.

FyoniBio · Midgard Science